{"id":"https://openalex.org/W4411287195","doi":"https://doi.org/10.1158/1557-3265.sabcs24-ps2-01","title":"Abstract PS2-01: Dalpiciclib versus placebo in combination with letrozole or anastrozole as first-line treatment for women with HR+/HER2- advanced breast cancer: prespecified final analysis of progression-free survival of the phase 3 DAWNA-2 trial","display_name":"Abstract PS2-01: Dalpiciclib versus placebo in combination with letrozole or anastrozole as first-line treatment for women with HR+/HER2- advanced breast cancer: prespecified final analysis of progression-free survival of the phase 3 DAWNA-2 trial","publication_year":2025,"publication_date":"2025-06-13","ids":{"openalex":"https://openalex.org/W4411287195","doi":"https://doi.org/10.1158/1557-3265.sabcs24-ps2-01"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.sabcs24-ps2-01","doi":"https://doi.org/10.1158/1557-3265.sabcs24-ps2-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-ps2-01","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Binghe Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Binghe Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101567919","display_name":"Pin Zhang","orcid":"https://orcid.org/0000-0002-7141-9541","observed_orcids":["https://orcid.org/0000-0002-7141-9541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pin Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100741380","display_name":"Qingyuan Zhang","orcid":"https://orcid.org/0000-0001-8116-5293","observed_orcids":["https://orcid.org/0000-0001-8116-5293","https://orcid.org/0000-0001-7618-4393","https://orcid.org/0000-0002-1763-9412","https://orcid.org/0000-0002-5003-8897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qingyuan Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091530007","display_name":"Zhongsheng Tong","orcid":"https://orcid.org/0000-0001-8060-5699","observed_orcids":["https://orcid.org/0000-0001-8060-5699","https://orcid.org/0000-0002-6495-3981"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhongsheng Tong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072667148","display_name":"Tao Sun","orcid":"https://orcid.org/0000-0001-5931-386X","observed_orcids":["https://orcid.org/0000-0001-5931-386X","https://orcid.org/0009-0005-2225-5105"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tao Sun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318325","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0002-9522-4474","observed_orcids":["https://orcid.org/0000-0002-9522-4474","https://orcid.org/0000-0003-4136-3409","https://orcid.org/0009-0009-9141-6389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101784505","display_name":"Quchang Ouyang","orcid":"https://orcid.org/0000-0003-1233-6081","observed_orcids":["https://orcid.org/0000-0003-1233-6081"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Quchang Ouyang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076833306","display_name":"Xichun Hu","orcid":"https://orcid.org/0000-0001-6148-9186","observed_orcids":["https://orcid.org/0000-0001-6148-9186","https://orcid.org/0009-0008-4760-9637","https://orcid.org/0000-0002-9892-699X","https://orcid.org/0000-0001-5856-830X","https://orcid.org/0000-0002-3488-6394","https://orcid.org/0000-0002-2157-2695"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xichun Hu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101793086","display_name":"Ying Cheng","orcid":"https://orcid.org/0000-0002-1517-501X","observed_orcids":["https://orcid.org/0000-0002-1517-501X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Cheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056443419","display_name":"Min Yan","orcid":"https://orcid.org/0000-0002-3911-748X","observed_orcids":["https://orcid.org/0000-0002-3911-748X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Yan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002727383","display_name":"Yueyin Pan","orcid":"https://orcid.org/0000-0003-0532-5368","observed_orcids":["https://orcid.org/0000-0003-0532-5368","https://orcid.org/0009-0006-8274-8902","https://orcid.org/0000-0002-8292-2812"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yueyin Pan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078066178","display_name":"Yuee Teng","orcid":"https://orcid.org/0000-0002-9198-9795","observed_orcids":["https://orcid.org/0000-0002-9198-9795"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuee Teng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106923074","display_name":"Xi Yan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xi Yan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100680047","display_name":"Ying Wang","orcid":"https://orcid.org/0000-0002-8566-875X","observed_orcids":["https://orcid.org/0000-0002-8566-875X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052316896","display_name":"Weimin Xie","orcid":"https://orcid.org/0009-0002-3266-1471","observed_orcids":["https://orcid.org/0009-0002-3266-1471","https://orcid.org/0009-0001-2408-489X","https://orcid.org/0000-0002-3821-7446"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weimin Xie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108811989","display_name":"Xiaohua Zeng","orcid":"https://orcid.org/0000-0001-5810-8055","observed_orcids":["https://orcid.org/0000-0001-5810-8055","https://orcid.org/0000-0001-6998-0623"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaohua Zeng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100726226","display_name":"Xiaojia Wang","orcid":"https://orcid.org/0000-0002-7005-0842","observed_orcids":["https://orcid.org/0000-0002-7005-0842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaojia Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110234","display_name":"Chang-Lu Hu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Changlu Hu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100452879","display_name":"Cuizhi Geng","orcid":"https://orcid.org/0000-0001-5541-5412","observed_orcids":["https://orcid.org/0000-0001-5541-5412","https://orcid.org/0000-0001-9912-4713","https://orcid.org/0009-0000-4889-4400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cuizhi Geng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100397251","display_name":"Hongwei Zhang","orcid":"https://orcid.org/0000-0002-5954-2061","observed_orcids":["https://orcid.org/0000-0002-5954-2061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongwei Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100397206","display_name":"Wenxin Li","orcid":"https://orcid.org/0000-0001-9866-6713","observed_orcids":["https://orcid.org/0000-0001-9866-6713","https://orcid.org/0009-0006-1615-433X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenxin Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005181416","display_name":"Xinhong Wu","orcid":"https://orcid.org/0000-0002-7544-5544","observed_orcids":["https://orcid.org/0000-0002-7544-5544","https://orcid.org/0000-0003-3536-0623"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinhong Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100667846","display_name":"Jincai Zhong","orcid":"https://orcid.org/0000-0002-2543-2788","observed_orcids":["https://orcid.org/0000-0002-2543-2788"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jincai Zhong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jingwei Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingwei Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043334299","display_name":"Yanxia Shi","orcid":"https://orcid.org/0000-0002-5414-8049","observed_orcids":["https://orcid.org/0000-0002-5414-8049","https://orcid.org/0009-0000-0791-1745"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanxia Shi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Mengzhu Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mengzhu Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101397493","display_name":"Xiaoyu Zhu","orcid":"https://orcid.org/0000-0002-1111-9141","observed_orcids":["https://orcid.org/0000-0002-1111-9141"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoyu Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"12_Supplement","first_page":"PS2","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dalpiciclib","display_name":"dalpiciclib","score":0.875},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/hr-her2-advanced-breast-cancer","display_name":"HR+/HER2- advanced breast cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.8220000267028809},{"id":"https://openalex.org/keywords/anastrozole","display_name":"anastrozole","score":1.0},{"id":"https://openalex.org/keywords/first-line-endocrine-therapy","display_name":"first-line endocrine therapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9769999980926514},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7310000061988831},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.46700000762939453},{"id":"https://openalex.org/keywords/menopausal-status","display_name":"menopausal status","score":0.5540000200271606},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.4790000021457672},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C2776215463","wikidata":"https://www.wikidata.org/wiki/Q419143","display_name":"Anastrozole","level":5,"score":0.9677666425704956},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.916999101638794},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7929271459579468},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6572645902633667},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6563442945480347},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6251713037490845},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5900536775588989},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4855465590953827},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.415131539106369},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.37740129232406616},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.36065882444381714},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.33173197507858276},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.08562356233596802},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07150295376777649}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.sabcs24-ps2-01","doi":"https://doi.org/10.1158/1557-3265.sabcs24-ps2-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-ps2-01","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4376126529","https://openalex.org/W4295837527","https://openalex.org/W4402134602","https://openalex.org/W7130754558","https://openalex.org/W4286297011","https://openalex.org/W4396588113","https://openalex.org/W3189200395","https://openalex.org/W7130700099","https://openalex.org/W4396587909","https://openalex.org/W7130749617"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Dalpiciclib":[2,314,418,620],"(a":[3],"highly":[4],"selective":[5],"and":[6,21,68,119,196,205,220,248,269,288,307,369,389,411,463,495,512],"potent":[7],"CDK4/6":[8],"inhibitor)":[9],"plus":[10,216,227,315,326],"letrozole":[11,165,217,228,316,327,523,626],"or":[12,151,166,218,229,296,317,328,371,524,627],"anastrozole":[13,318,329,525,628],"as":[14,426,544,629],"first-line":[15,630],"treatment":[16,551,631],"led":[17],"to":[18,42,135,324,431,504,522,527],"a":[19,86,132,152],"statistically":[20],"clinically":[22],"significant":[23],"improvement":[24],"in":[25,34,97,131,211,222,265,272,284,290,299,303,310,360,385,392,459,466,481,487,491,497,548,623],"progression-free":[26,643],"survival":[27,475,644],"(PFS)":[28],"compared":[29,323],"with":[30,36,276,356,531,555,625,634],"endocrine":[31,160,277],"therapy":[32,258,278],"alone":[33],"women":[35,363,373,633],"HR+/HER2-":[37,122,556,635],"advanced":[38,124,557,636],"breast":[39,125,558,637],"cancer,":[40,559],"according":[41],"the":[43,47,62,184,212,223,232,235,245,254,266,273,280,285,291,304,311,386,393,400,422,429,452,460,467,492,498,549,646,655],"interim":[44],"analysis":[45,65,72,186,641],"of":[46,66,78,107,117,403,451,489,514,520,561,642,645,654],"DAWNA-2":[48,83,100,649],"trial":[49,92,101,650],"(NCT03966898;":[50],"Xu":[51],"et":[52],"al.,":[53],"Lancet":[54],"Oncology,":[55],"2023).":[56],"In":[57],"this":[58,542],"report,":[59],"we":[60],"present":[61],"prespecified":[63,639],"final":[64,640],"PFS":[67,322,354,529],"an":[69,113,397,545],"updated":[70,185],"safety":[71,534],"after":[73,537],"more":[74],"than":[75],"one":[76,148],"year":[77],"additional":[79],"follow-up.":[80],"Methods:":[81],"The":[82,99,174,180,353,472,518],"study":[84,424],"was":[85,177,187,239,259,358,405,477,508],"randomized,":[87],"double-blind,":[88],"multicenter":[89],"phase":[90,647],"3":[91,648],"conducted":[93],"at":[94],"42":[95],"centers":[96],"China.":[98],"enrolled":[102,204],"patients":[103,202,264,302,383,458,490,554],"aged":[104],"18\u201375":[105],"years,":[106],"any":[108],"menopausal":[109,562],"status,":[110],"who":[111],"had":[112,470],"ECOG":[114],"performance":[115],"status":[116],"0\u20131":[118],"pathologically":[120],"confirmed":[121],"untreated":[123],"cancer.":[126],"Patients":[127],"were":[128,203],"randomly":[129],"assigned":[130],"2:1":[133],"ratio":[134,344],"receive":[136],"oral":[137],"dalpiciclib":[138,213,246,267,286,305,357,387,461,493,521],"(150":[139],"mg":[140,164,168],"per":[141],"day":[142],"for":[143,183,244,253,510,553,632],"three":[144],"weeks,":[145],"followed":[146],"by":[147,261,428],"week":[149],"off)":[150],"matching":[153],"placebo.":[154],"Both":[155],"groups":[156],"also":[157],"received":[158,260],"continuous":[159],"therapy,":[161],"either":[162],"2.5":[163],"1":[167],"anastrozole,":[169],"administered":[170],"orally":[171],"once":[172],"daily.":[173],"primary":[175],"endpoint":[176],"investigator-assessed":[178,321],"PFS.":[179],"data":[181,233,453],"cutoff":[182,454],"March":[188],"31,":[189],"2024.":[190],"Results:":[191],"Between":[192],"July":[193],"19,":[194],"2019,":[195],"December":[197],"25,":[198],"2020,":[199],"456":[200],"eligible":[201],"randomized":[206],"into":[207],"two":[208],"groups:":[209],"303":[210],"group":[214,225,247,268,287,306,388,395,462,469,494],"(dalpiciclib":[215],"anastrozole)":[219],"153":[221],"placebo":[224,255,274,292,312,325,394,468,499,622],"(placebo":[226],"anastrozole).":[230],"At":[231],"cutoff,":[234],"median":[236,401,473],"follow-up":[237],"duration":[238,402],"40.6":[240],"months":[241,250,333,339,407,413,441],"(IQR":[242,251],"30.3-45.1)":[243],"38.9":[249],"27.5-44.6)":[252],"group.":[256,313,500],"Post-discontinuation":[257],"154":[262],"(50.8%)":[263],"101":[270],"(66.0%)":[271],"group,":[275],"being":[279],"most":[281],"common":[282],"(32.7%":[283],"49.7%":[289],"group).":[293],"Disease":[294],"progression":[295],"death":[297],"occurred":[298,486],"160":[300],"(52.8%)":[301],"109":[308],"(71.2%)":[309],"significantly":[319],"prolonged":[320,538],"(median":[330,435],"PFS:":[331],"33.4":[332],"[95%":[334,340,347,366,376,442,447],"CI":[335,341,348,367,377,409,415,443,448],"29.6-39.0]":[336],"vs.":[337,439],"19.3":[338],"16.5-22.5];":[342],"hazard":[343],"[HR]":[345],"0.56":[346],"0.44-0.72];":[349],"one-sided":[350],"p":[351],"<0.0001).":[352],"benefit":[355],"consistent":[359],"both":[361,482],"postmenopausal":[362],"(HR":[364,374],"0.54":[365],"0.40-0.74])":[368],"pre-":[370],"perimenopausal":[372],"0.63":[375],"0.41-0.95]).":[378],"Per":[379],"investigator":[380],"assessment,":[381],"181":[382],"(59.7%)":[384],"76":[390],"(49.7%)":[391],"achieved":[396],"objective":[398],"response;":[399],"response":[404],"36.1":[406],"(95%":[408,414],"29.4-45.8)":[410],"16.4":[412],"13.8-24.8),":[416],"respectively.":[417,516],"showed":[419],"benefits":[420,530],"beyond":[421],"initial":[423],"treatment,":[425],"indicated":[427],"time":[430],"first":[432],"subsequent":[433],"chemotherapy":[434],"not":[436,478],"reached":[437],"[NR]":[438],"47.4":[440],"31.4-NR];":[444],"HR":[445],"0.76":[446],"0.56-1.02]).":[449],"As":[450],"date,":[455],"80":[456],"(26.4%)":[457],"46":[464],"(30.1%)":[465],"died.":[471],"overall":[474],"(OS)":[476],"yet":[479],"mature":[480],"groups.":[483],"Serious":[484],"AEs":[485],"17.5%":[488],"7.8%":[496],"Treatment":[501],"discontinuation":[502],"due":[503],"adverse":[505],"events":[506],"(AEs)":[507],"reported":[509],"4.6%":[511],"2.0%":[513],"patients,":[515],"Conclusion:":[517],"addition":[519],"continues":[526],"demonstrate":[528],"no":[532],"new":[533],"signals":[535],"identified":[536],"follow-up,":[539],"further":[540],"supporting":[541],"regimen":[543],"alternative":[546],"option":[547],"current":[550],"landscape":[552],"regardless":[560],"status.":[563],"Citation":[564],"Format:":[565],"Binghe":[566],"Xu,":[567,613],"Pin":[568],"Zhang,":[569,571,605],"Qingyuan":[570],"Zhongsheng":[572],"Tong,":[573],"Tao":[574],"Sun,":[575],"Wei":[576],"Li,":[577,607],"Quchang":[578],"Ouyang,":[579],"Xichun":[580],"Hu,":[581,601],"Ying":[582,592],"Cheng,":[583],"Min":[584],"Yan,":[585,591],"Yueyin":[586],"Pan,":[587],"Yuee":[588],"Teng,":[589],"Xi":[590],"Wang,":[593,599],"Weimin":[594],"Xie,":[595],"Xiaohua":[596],"Zeng,":[597],"Xiaojia":[598],"Changlu":[600],"Cuizhi":[602],"Geng,":[603],"Hongwei":[604],"Wenxin":[606],"Xinhong":[608],"Wu,":[609],"Jincai":[610],"Zhong,":[611],"Jingwei":[612],"Yanxia":[614],"Shi,":[615],"Mengzhu":[616],"Yu,":[617],"Xiaoyu":[618],"Zhu.":[619],"versus":[621],"combination":[624],"cancer:":[638],"[abstract].":[651],"In:":[652],"Proceedings":[653],"San":[656,665],"Antonio":[657],"Breast":[658],"Cancer":[659,672],"Symposium":[660],"2024;":[661],"2024":[662],"Dec":[663],"10-13;":[664],"Antonio,":[666],"TX.":[667],"Philadelphia":[668],"(PA):":[669],"AACR;":[670],"Clin":[671],"Res":[673],"2025;31(12":[674],"Suppl):Abstract":[675],"nr":[676],"PS2-01.":[677]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-10T00:00:00"}